Oral Nadolol for the Treatment of Adults With Mild Asthma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

May 31, 2009

Study Completion Date

June 30, 2009

Conditions
Asthma
Interventions
DRUG

nadolol

Nadolol, oral taken daily, doses will be escalated every two weeks over 13 weeks following a 2 week run-in.

Trial Locations (1)

77030

Baylor College of Medicine, Houston

All Listed Sponsors
collaborator

University of Houston

OTHER

collaborator

Sandler Program for Asthma Research

OTHER

collaborator

Baylor College of Medicine

OTHER

lead

Invion, Inc.

INDUSTRY

NCT00670267 - Oral Nadolol for the Treatment of Adults With Mild Asthma | Biotech Hunter | Biotech Hunter